2024 Q1 Form 10-Q Financial Statement
#000149315224032270 Filed on August 14, 2024
Income Statement
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
Revenue | $538.4K | $0.00 |
YoY Change | ||
Cost Of Revenue | $1.959M | $1.142M |
YoY Change | 71.58% | |
Gross Profit | $3.053M | $3.941M |
YoY Change | -22.54% | |
Gross Profit Margin | 567.02% | |
Selling, General & Admin | $1.825M | $764.2K |
YoY Change | 138.84% | 331.68% |
% of Gross Profit | 59.78% | 19.39% |
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $14.32K | $10.34K |
YoY Change | 38.46% | |
% of Gross Profit | 0.47% | 0.26% |
Operating Expenses | $3.997M | $764.2K |
YoY Change | 422.98% | 331.68% |
Operating Profit | -$943.7K | -$4.905M |
YoY Change | -80.76% | |
Interest Expense | $96.51K | $95.76K |
YoY Change | 0.78% | -1615.19% |
% of Operating Profit | ||
Other Income/Expense, Net | -$358.2K | -$446.7K |
YoY Change | -19.81% | |
Pretax Income | -$668.5K | |
YoY Change | 264.58% | |
Income Tax | -$10.85K | |
% Of Pretax Income | ||
Net Earnings | -$1.302M | -$657.6K |
YoY Change | 97.97% | 258.66% |
Net Earnings / Revenue | -241.79% | |
Basic Earnings Per Share | -$0.22 | -$446.20 |
Diluted Earnings Per Share | -$0.22 | -$0.14 |
COMMON SHARES | ||
Basic Shares Outstanding | 5.995M shares | 11.99K shares |
Diluted Shares Outstanding | 5.995M shares | 11.99K shares |
Balance Sheet
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $7.826M | $9.756M |
YoY Change | -19.79% | -92.42% |
Cash & Equivalents | $7.826M | $595.5K |
Short-Term Investments | $0.00 | $9.161M |
Other Short-Term Assets | $20.41K | |
YoY Change | -93.53% | |
Inventory | $2.336M | |
Prepaid Expenses | $20.41K | |
Receivables | $3.317M | |
Other Receivables | ||
Total Short-Term Assets | $9.777M | |
YoY Change | -92.42% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $166.7K | |
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $1.906M | |
YoY Change | ||
Total Long-Term Assets | $0.00 | |
YoY Change | ||
TOTAL ASSETS | ||
Total Short-Term Assets | $9.777M | |
Total Long-Term Assets | $0.00 | |
Total Assets | $9.777M | |
YoY Change | -92.42% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $866.5K | |
YoY Change | 5414.89% | |
Deferred Revenue | $1.795M | |
YoY Change | ||
Short-Term Debt | $0.00 | |
YoY Change | ||
Long-Term Debt Due | $1.865M | |
YoY Change | 273.0% | |
Total Short-Term Liabilities | $9.695M | $2.795M |
YoY Change | 246.85% | 420.78% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | |
YoY Change | ||
Other Long-Term Liabilities | $81.56K | $4.428M |
YoY Change | -98.16% | 0.0% |
Total Long-Term Liabilities | $81.56K | $4.428M |
YoY Change | -98.16% | 0.0% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $9.695M | $2.795M |
Total Long-Term Liabilities | $81.56K | $4.428M |
Total Liabilities | $24.55M | $7.223M |
YoY Change | 239.95% | 45.49% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$13.66M | -$6.441M |
YoY Change | 112.1% | 70.55% |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$9.073M | -$6.440M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $15.48M | $9.777M |
YoY Change | 58.34% | -92.42% |
Cashflow Statement
Concept | 2024 Q1 | 2023 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.302M | -$657.6K |
YoY Change | 97.97% | 258.66% |
Depreciation, Depletion And Amortization | $14.32K | $10.34K |
YoY Change | 38.46% | |
Cash From Operating Activities | $2.669M | -$366.6K |
YoY Change | -827.86% | 266.27% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $332.3K | $46.65K |
YoY Change | 612.42% | |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $120.9M | |
YoY Change | ||
Cash From Investing Activities | -$332.3K | $120.9M |
YoY Change | -100.27% | |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | $92.13K | -120.9M |
YoY Change | -100.08% | |
NET CHANGE | ||
Cash From Operating Activities | $2.669M | -366.6K |
Cash From Investing Activities | -$332.3K | 120.9M |
Cash From Financing Activities | $92.13K | -120.9M |
Net Change In Cash | $2.428M | -366.6K |
YoY Change | -762.34% | 266.27% |
FREE CASH FLOW | ||
Cash From Operating Activities | $2.669M | -$366.6K |
Capital Expenditures | $332.3K | $46.65K |
Free Cash Flow | $2.336M | -$413.3K |
YoY Change | -665.29% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
usd | |
CY2023Q4 | TRUG |
Other Accrued Liabilities Current Assumed In Merger
OtherAccruedLiabilitiesCurrentAssumedInMerger
|
usd | |
CY2023Q4 | TRUG |
Long Term Notes Payable Assumed In Merger
LongTermNotesPayableAssumedInMerger
|
usd | |
CY2023Q4 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
usd | |
CY2024Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
usd | |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
usd | |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2024Q1 | TRUG |
Other Comprehensive Income Unrealized Gain In Fair Value Of Short Term Investments
OtherComprehensiveIncomeUnrealizedGainInFairValueOfShortTermInvestments
|
usd | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
usd | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
usd | |
CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
CY2024Q1 | us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
usd | |
CY2023Q1 | us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
usd | |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
usd | |
CY2023Q1 | TRUG |
Change In Other Comprehensive Income
ChangeInOtherComprehensiveIncome
|
usd | |
CY2024Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | |
CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
usd | |
CY2024Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
usd | |
CY2023Q1 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | |
CY2023Q1 | TRUG |
Proceeds Of Pipe Loan Net Of Oid Discount
ProceedsOfPipeLoanNetOfOidDiscount
|
usd | |
CY2023Q1 | TRUG |
Payments Of Costs Of Merger From Pipe Loan
PaymentsOfCostsOfMergerFromPipeLoan
|
usd | |
CY2023Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
usd | |
CY2023Q1 | TRUG |
Increase In Other Liabilities
IncreaseInOtherLiabilities
|
usd | |
CY2024Q1 | TRUG |
Payments Of Dividend
PaymentsOfDividend
|
usd | |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023Q1 | us-gaap |
Notes Issued1
NotesIssued1
|
usd | |
CY2023Q1 | TRUG |
Accrued Liabilities Assumed In Merger
AccruedLiabilitiesAssumedInMerger
|
usd | |
CY2023Q1 | TRUG |
Remeasurement Of Common Stock Exchangedissued In Merger
RemeasurementOfCommonStockExchangedissuedInMerger
|
usd | |
CY2024Q1 | TRUG |
Distributions Payments For Tax Liabilities
DistributionsPaymentsForTaxLiabilities
|
usd | |
CY2023Q4 | TRUG |
Distributions Payments For Tax Liabilities
DistributionsPaymentsForTaxLiabilities
|
usd | |
CY2024Q1 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
363879 | usd |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
542631 | usd |
CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
459872 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
804405 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
1125495 | usd |
CY2024Q1 | TRUG |
Other Accrued Liabilities Current Assumed In Merger
OtherAccruedLiabilitiesCurrentAssumedInMerger
|
295008 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
347809 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
334255 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
9694647 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10668339 | usd |
CY2024Q1 | TRUG |
Long Term Notes Payable Assumed In Merger
LongTermNotesPayableAssumedInMerger
|
1565000 | usd |
CY2024Q1 | us-gaap |
Long Term Loans Payable
LongTermLoansPayable
|
4320947 | usd |
CY2024Q1 | TRUG |
Dividend Notes Payable
DividendNotesPayable
|
4023923 | usd |
CY2023Q4 | TRUG |
Dividend Notes Payable
DividendNotesPayable
|
4023923 | usd |
CY2024Q1 | TRUG |
Gross Sales Royalty Payable
GrossSalesRoyaltyPayable
|
1000000 | usd |
CY2023Q4 | TRUG |
Gross Sales Royalty Payable
GrossSalesRoyaltyPayable
|
1000000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
574363 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
668228 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
81560 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
63015 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
24553285 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
19687288 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
4692 | shares |
CY2023Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
4692 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2037000 | usd |
CY2023Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
2037000 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
6623839 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
10479738 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-1662 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-13660788 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-12358924 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9072623 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3917728 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15480662 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
15769560 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
5083199 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
3052999 | usd |
CY2024Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
329888 | usd |
CY2023Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
215632 | usd |
CY2024Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1841595 | usd |
CY2023Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
2231434 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1825201 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
6398885 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3996684 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
8845951 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-943685 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4904520 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
30587 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
21497 | usd |
CY2024Q1 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
384854 | usd |
CY2023Q1 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
468154 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
-3912 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-358179 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-446657 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
-1301864 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
|
-5351177 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1301864 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5351177 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.22 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.22 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-446.15 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-446.15 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5994704 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5994704 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11994 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11994 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1301864 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5351177 | usd |
CY2023Q1 | TRUG |
Other Comprehensive Income Unrealized Gain In Fair Value Of Short Term Investments
OtherComprehensiveIncomeUnrealizedGainInFairValueOfShortTermInvestments
|
-11914 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1301864 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-5339263 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3430759 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
4493333 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-11914 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4276689 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3917728 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3917728 | usd |
CY2024Q1 | TRUG |
Realized Gain In Fair Value Of Short Term Investments
RealizedGainInFairValueOfShortTermInvestments
|
1662 | usd |
CY2024Q1 | TRUG |
Stock Issued During Values In Common Stock Exchanged In Merger
StockIssuedDuringValuesInCommonStockExchangedInMerger
|
-3854693 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1301864 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9072623 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9072623 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1301864 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5351177 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
36105 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
13756 | usd |
CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
947 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
257233 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
82454 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
72520 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
205920 | usd |
CY2024Q1 | TRUG |
Change In Other Comprehensive Income
ChangeInOtherComprehensiveIncome
|
1662 | usd |
CY2023Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
4493333 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-468422 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-367541 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
216569 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1122034 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-200278 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-70178 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
-2478953 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
|
40422 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
1875000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1146347 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
526376 | usd |
CY2024Q1 | TRUG |
Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
|
90524 | usd |
CY2023Q1 | TRUG |
Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
|
-594071 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
82759 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
128049 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-321090 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-158586 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-80311 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-65572 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2668617 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3071956 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
332342 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
46650 | usd |
CY2023Q1 | TRUG |
Payments For Proceeds From Long Term Assets
PaymentsForProceedsFromLongTermAssets
|
2421060 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-332342 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2467710 | usd |
CY2023Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
1875000 | usd |
CY2024Q1 | us-gaap |
Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
|
15716 | usd |
CY2024Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
2295 | usd |
CY2023Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
33616 | usd |
CY2024Q1 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
268500 | usd |
CY2024Q1 | TRUG |
Proceeds Of Pipe Loan Net Of Oid Discount
ProceedsOfPipeLoanNetOfOidDiscount
|
4320000 | usd |
CY2024Q1 | TRUG |
Proceeds Of Cash Acquired In Merger
ProceedsOfCashAcquiredInMerger
|
103818 | usd |
CY2024Q1 | TRUG |
Payments Of Costs Of Merger From Pipe Loan
PaymentsOfCostsOfMergerFromPipeLoan
|
2082787 | usd |
CY2024Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
1980937 | usd |
CY2024Q1 | TRUG |
Increase In Other Liabilities
IncreaseInOtherLiabilities
|
-18545 | usd |
CY2023Q1 | TRUG |
Payments Of Dividend
PaymentsOfDividend
|
-42963 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
92128 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1884347 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
2428403 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3655319 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
5397564 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9656266 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7825967 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
6000947 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
302095 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
275735 | usd |
CY2024Q1 | us-gaap |
Notes Issued1
NotesIssued1
|
1565000 | usd |
CY2024Q1 | TRUG |
Accrued Liabilities Assumed In Merger
AccruedLiabilitiesAssumedInMerger
|
310724 | usd |
CY2024Q1 | TRUG |
Remeasurement Of Common Stock Exchangedissued In Merger
RemeasurementOfCommonStockExchangedissuedInMerger
|
-1875724 | usd |
CY2024Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
103818 | usd |
CY2024Q1 | TRUG |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Proceeds From Investment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetProceedsFromInvestment
|
2237213 | usd |
CY2024Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
|
310724 | usd |
CY2024Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt
|
1565000 | usd |
CY2024Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
|
465307 | usd |
CY2024Q1 | TRUG |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt Gross
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebtGross
|
4800000 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.10 | pure |
CY2024Q1 | TRUG |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Unamortized Discount
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUnamortizedDiscount
|
480000 | usd |
CY2024Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Long Term Debt
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
|
4320000 | usd |
CY2024Q1 | TRUG |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Payment Of Closing Costs And Other Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesPaymentOfClosingCostsAndOtherExpenses
|
2082787 | usd |
CY2024Q1 | TRUG |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Net Proceeds From Convertible Notes Payable In Merger
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNetProceedsFromConvertibleNotesPayableInMerger
|
2237213 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84A_eus-gaap--UseOfEstimates_zYruChISGh2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zlsxFK7vSic6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company prepares its financial statements in accordance with accounting principles generally accepted in the United States of America, which requires management to use its judgment to make estimates and assumptions that affect the reported amounts of assets and liabilities and related disclosures at the date of the financial statements and the reported amounts of expenses during the reported period. These assumptions and estimates could have a material effect on the financial statements. Actual results may differ materially from those estimates. The Company’s management periodically reviews estimates on an ongoing basis based on information currently available, and changes in facts and circumstances may cause the Company to revise these estimates. Significant estimates include estimates used in the valuation allowance related to deferred tax assets and capitalized software costs. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
7825967 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
5394564 | usd |
CY2024Q1 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2024Q1 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
6742396 | usd |
CY2023Q4 | us-gaap |
Cash Uninsured Amount
CashUninsuredAmount
|
4251124 | usd |
CY2024Q1 | us-gaap |
Marketable Securities
MarketableSecurities
|
0 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1395688 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1227135 | usd |
CY2024Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
448360 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
429050 | usd |
CY2024Q1 | us-gaap |
Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
|
18463 | usd |
CY2024Q1 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
18463 | usd |
CY2024Q1 | TRUG |
Capitalized Software Development Costs Net
CapitalizedSoftwareDevelopmentCostsNet
|
363889 | usd |
CY2023Q4 | TRUG |
Capitalized Software Development Costs Net
CapitalizedSoftwareDevelopmentCostsNet
|
50000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P12M | |
CY2024Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
171502 | usd |
CY2023Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
171502 | usd |
CY2024Q1 | us-gaap |
Revenues
Revenues
|
538427 | usd |
CY2023Q1 | us-gaap |
Revenues
Revenues
|
538427 | usd |
CY2024Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
329888 | usd |
CY2023Q1 | us-gaap |
Royalty Expense
RoyaltyExpense
|
215632 | usd |
CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_ztxwWlOdCXzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zQl46Bs9KaDk">Concentration of Credit and Supplier Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits and trade accounts receivable. Credit risk can be negatively impacted by adverse changes in the economy or by disruptions in the credit markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash deposits with established commercial banks. At times, balances may exceed federally insured limits. We have not experienced any losses in such accounts and do not believe that we are exposed to any significant credit risk associated with our cash deposits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We believe that credit risk with respect to trade accounts receivable is somewhat mitigated by our large number of geographically diverse customers and our credit evaluation procedures. We record trade accounts receivables at sales value and establish specific reserves for certain customer accounts identified as known collection problems due to insolvency, disputes or other collection issues. The amounts of the specific reserves estimated by management are determined by a loss rate model based on delinquency. We maintain reserves for potential losses. There were no customers that accounted for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_z9VAzN2ydoYh" title="Concentration risk percentage"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20230101__20230331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomersMember_zHvPf4Kd8e12" title="Concentration risk percentage">10.0</span></span>% of our revenues for the three months ended March 31, 2024 and 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We purchase a significant amount of parts we consume in manufacturing our simulators from nationally known original equipment manufacturers, many of whom we have had over a <span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__srt--RangeAxis__srt--MinimumMember_zdrnREnAy0L4" title="Property plant and equipment useful life">10</span> to <span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240331__srt--RangeAxis__srt--MaximumMember_zB2MhcULWBUl" title="Property plant and equipment useful life">15</span> year relationship. While we do not have long-term contracts, we do issue purchase orders based on quoted prices terms. During the three months ended March 31, 2024, we purchased approximately <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20240101__20240331__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zJnlftEZOCfl" title="Concentration risk percentage">50.4</span>% of our assembly parts from six manufacturers. We believe that while there are alternative suppliers, for the parts and equipment, we purchase in each of the principal product categories, termination of one or more of our relationships with any of our major suppliers of equipment could have a material adverse effect on our business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2024Q1 | us-gaap |
Trade Receivables Held For Sale Amount
TradeReceivablesHeldForSaleAmount
|
3316779 | usd |
CY2023Q4 | us-gaap |
Trade Receivables Held For Sale Amount
TradeReceivablesHeldForSaleAmount
|
3458625 | usd |
CY2024Q1 | TRUG |
Other Accounts Receivable
OtherAccountsReceivable
|
9360 | usd |
CY2023Q4 | TRUG |
Other Accounts Receivable
OtherAccountsReceivable
|
167382 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
3326138 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
3626007 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1395688 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1227135 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
1930450 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
2398872 | usd |
CY2024Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2784013 | usd |
CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
2548134 | usd |
CY2024Q1 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
448360 | usd |
CY2023Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
429050 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
2335653 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
2119084 | usd |
CY2023Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
2511336 | usd |
CY2024Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1905983 | usd |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1905983 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1065332 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1115332 | usd |
CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
898666 | usd |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
881024 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
166666 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
234308 | usd |
CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
14317 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
10340 | usd |
CY2024Q1 | us-gaap |
Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
|
382342 | usd |
CY2024Q1 | us-gaap |
Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
|
18463 | usd |
CY2024Q1 | us-gaap |
Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
|
363879 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1794748 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1704224 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1704224 | usd |
CY2024Q1 | TRUG |
Long Term Notes Payable Assumed In Merger
LongTermNotesPayableAssumedInMerger
|
1565000 | usd |
CY2024Q1 | us-gaap |
Notes And Loans Payable
NotesAndLoansPayable
|
1565500 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
968500 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
287000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
287000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
287000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
1829500 | usd |
CY2024Q1 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
802738 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
802738 | usd |
CY2022Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
4800 | shares |
CY2022Q2 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2022Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
9600 | usd |
CY2022Q2 | TRUG |
Conversion Price Of Common Stock Percentage
ConversionPriceOfCommonStockPercentage
|
0.70 | pure |
CY2022Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
|
0.50 | pure |
CY2022Q4 | us-gaap |
Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
|
1387060 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
450000 | usd |
CY2022 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
145992 | usd |
CY2022Q4 | TRUG |
Warrants And Convertible Notes
WarrantsAndConvertibleNotes
|
445032 | usd |
CY2022Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
192857 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
450000 | usd |
CY2022 | us-gaap |
Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
|
16480 | usd |
CY2023Q1 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2023-07-31 | |
CY2023Q1 | us-gaap |
Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
|
375000 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
18000 | shares |
CY2024Q1 | TRUG |
Debt Instrument Remaining Original Issuance Discount
DebtInstrumentRemainingOriginalIssuanceDiscount
|
0 | usd |
CY2023Q1 | TRUG |
Debt Instrument Remaining Original Issuance Discount
DebtInstrumentRemainingOriginalIssuanceDiscount
|
0 | usd |
CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2023 | us-gaap |
Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
|
0 | usd |
CY2022 | us-gaap |
Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
|
0 | usd |
CY2021 | us-gaap |
Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
|
7395694 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
|
1965706 | usd |
CY2022 | TRUG |
Interest Dividend Rate Percentage
InterestDividendRatePercentage
|
0.0600 | pure |
CY2024Q1 | TRUG |
Accrued Interest On Dividends Payable
AccruedInterestOnDividendsPayable
|
274242 | usd |
CY2023Q4 | TRUG |
Accrued Interest On Dividends Payable
AccruedInterestOnDividendsPayable
|
274242 | usd |
CY2024Q1 | TRUG |
Dividend Notes Payable
DividendNotesPayable
|
4023923 | usd |
CY2023Q4 | TRUG |
Dividend Notes Payable
DividendNotesPayable
|
4023923 | usd |
CY2024Q1 | TRUG |
Gross Sales Royalty Payable
GrossSalesRoyaltyPayable
|
1000000 | usd |
CY2024Q1 | TRUG |
Aggregate Purchase Installment Percentage
AggregatePurchaseInstallmentPercentage
|
75 | pure |
CY2024Q1 | us-gaap |
Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
|
750000 | usd |
CY2024Q1 | TRUG |
Aggregate Purchase Installment Percentage
AggregatePurchaseInstallmentPercentage
|
75 | pure |
CY2024Q1 | TRUG |
Gross Sales Royalty Payable
GrossSalesRoyaltyPayable
|
1000000 | usd |
CY2024Q1 | TRUG |
Aggregate Purchase Installment Percentage
AggregatePurchaseInstallmentPercentage
|
75 | pure |
CY2024Q1 | TRUG |
Aggregate Purchase Installment Amount
AggregatePurchaseInstallmentAmount
|
22500000 | usd |
CY2015Q2 | TRUG |
Royalty Percentage
RoyaltyPercentage
|
0.024 | pure |
CY2024Q1 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1000000 | usd |
CY2023 | us-gaap |
Payments For Royalties
PaymentsForRoyalties
|
1000000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
96509 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
9124 | usd |
CY2023Q4 | us-gaap |
Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
|
326515 | usd |
CY2023Q1 | TRUG |
Accrued Credit Cards
AccruedCreditCards
|
270805 | usd |
CY2023Q4 | TRUG |
Accrued Credit Cards
AccruedCreditCards
|
240989 | usd |
CY2023Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
140000 | usd |
CY2023Q4 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
140000 | usd |
CY2023Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
34921 | usd |
CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
43891 | usd |
CY2023Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
349556 | usd |
CY2023Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
374100 | usd |
CY2023Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
804405 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
1125495 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q1 | us-gaap |
Conversion Of Stock Description
ConversionOfStockDescription
|
Each holder of a private right received one-tenth (1/10) of one share of DMAQ Class A common stock upon consummation of initial business combination | |
CY2024Q1 | TRUG |
Redemption Of Shares
RedemptionOfShares
|
379687 | shares |
CY2024Q1 | us-gaap |
Cash
Cash
|
2000000 | usd |
CY2024Q1 | TRUG |
Stock Based On Performance Including Services Percentage
StockBasedOnPerformanceIncludingServicesPercentage
|
Once services are performed, the first consultant will be provided a 3% stock grant; while the second consultant will be provided up to 7% of stock based on performance deliverables including: 1.75% on consummation of an initial bridge loan agreement, 1.75% on engaging an investment banker, 1.75% upon filing an S-1 including financial statements and footnotes, and 1.75% upon the closing of an initial public offering. The second consultant will be provided warrants at a 20% discount to the then current price per share, for up to 2% for achieving a $250 million valuation and 3% more for a $500 million valuation, as well as another 2% for opening the first franchise location, and 3% more once 100 franchise locations have been sold. As of the date of this filing, no stock grants or awards have been issued. | |
CY2024Q1 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2024Q1 | us-gaap |
Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
|
Tax positions that meet the more likely than not threshold are then measured using a probability weighted approach recognizing the largest amount of tax benefit that is greater than 50% likely of being realized upon ultimate settlement. | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1301864 | usd |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | pure |
CY2024Q1 | TRUG |
Operating Loss Carryforwards Current
OperatingLossCarryforwardsCurrent
|
267000 | usd |
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.1000 | pure |
CY2022Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0590 | pure |
CY2024Q1 | TRUG |
Schedule Of Operating Lease Right Of Use Asset Table Text Bock
ScheduleOfOperatingLeaseRightOfUseAssetTableTextBock
|
<p id="xdx_897_ecustom--ScheduleOfOperatingLeaseRightOfUseAssetTableTextBock_zbpeTcM8HOj1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use asset:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BF_zp977JEKC32d" style="display: none">SCHEDULE OF RIGHT OF USE ASSET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 92%; margin-left: 0.5in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_4B2_zws3hGaNmQb5" style="border-bottom: Black 2.5pt double; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_431_c20240101__20240331_eus-gaap--OperatingLeaseRightOfUseAsset_iS_zg0MfKHqLF5l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: justify; padding-bottom: 2.5pt">As of December 31, 2023</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">972,663</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_zCU96CtpYkG6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">82,454</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_43A_c20240101__20240331_eus-gaap--OperatingLeaseRightOfUseAsset_iE_ziY8WRiIDAw6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">As of March 31, 2024$</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">890,209</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
972663 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
82454 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
890209 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1002483 | usd |
CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
80311 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
922172 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
303478 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
406990 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
140163 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
144227 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
60809 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1055667 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
133495 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
922172 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
347809 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
574363 | usd |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |